ArticleInternational journal of molecular sciences2023

A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.

Noriyuki Okonogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.